drugset / Trial / NCT06405724

Comparison of the Ultrasound-guided Paravertebral Nerve Block With Liposomal Bupivacaine Versus Ropivacaine for Post-Surgical Pain After Video-Assisted Thoracoscopic Surgery

NCT06405724

Phase 3 Unknown 84 enrolled Feng Gao
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Prospective, randomized, and controlled trial to compare the postoperative pain management of paravertebral nerve block with liposomal bupivacaine to ropivacaine in patients undergoing elective thoracoscopic surgery.

Timeline

Start
2024-05-10
Primary completion
2025-12-21
Completion
2025-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 133 mg
Comparator Ropivacaine Other / unclassified 0.5 %
Comparator Ropivacaine Other / unclassified 20 ml

Indications

No indication recorded.